[{"Assets_0_Q2_USD":398387000.0,"CommonStockSharesOutstanding_0_Q2_shares":79059764.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-44946000.0,"NetIncomeLoss_1_Q2_USD":-24397000.0,"NetIncomeLoss_2_Q2_USD":-45890000.0,"StockholdersEquity_0_Q2_USD":176434000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2639000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":9266000.0,"Ticker":"KDNY","CIK":"1435049","name":"ADURO BIOTECH, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180801"}]